Results 21 to 30 of about 216,439 (378)

Chronic myeloid leukemia cells require the bone morphogenic protein pathway for cell cycle progression and self-renewal [PDF]

open access: yes, 2018
Leukaemic stem cell (LSC) persistence remains a major obstacle to curing chronic myeloid leukaemia (CML). The bone morphogenic protein (BMP) pathway is deregulated in CML, with altered expression and response to the BMP ligands shown to impact on LSC ...
Busch, Caroline   +6 more
core   +2 more sources

Moving treatment-free remission into mainstream clinical practice in CML.

open access: yesBlood, 2016
The dramatic success of tyrosine kinase inhibitors (TKIs) has led to the widespread perception that chronic myeloid leukemia (CML) has become another chronic disease, where lifelong commitment to pharmacologic control is the paradigm.
T. Hughes, D. Ross
semanticscholar   +1 more source

Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia [PDF]

open access: yes, 2014
Chronic myeloid leukemia (CML) is a stem cell (SC) neoplasm characterized by the BCR/ABL1 oncogene. Although mechanisms of BCR/ABL1-induced transformation are well-defined, little is known about effector-molecules contributing to malignant expansion and ...
Bilban, Martin   +15 more
core   +1 more source

Assessing circularity interventions: a review of EEIOA-based studies

open access: yesJournal of Economic Structures, 2018
Environmentally extended input–output analysis (EEIOA) can be applied to assess the economic and environmental implications of a transition towards a circular economy. In spite of the existence of several such applications, a systematic assessment of the
Glenn A. Aguilar-Hernandez   +4 more
doaj   +1 more source

The c-Myc-regulated lncRNA NEAT1 and paraspeckles modulate imatinib-induced apoptosis in CML cells

open access: yesMolecular Cancer, 2018
Chronic myeloid leukemia (CML) is a clonal disease characterized by the presence of the constitutively active tyrosine kinase BCR-ABL oncoprotein. Although BCR-ABL is crucially important for pathogenesis and treatment response, it is thought that some ...
Chengwu Zeng   +10 more
semanticscholar   +1 more source

Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP.

open access: yesBlood Advances, 2019
Several papers authored by international experts have proposed recommendations on the management of BCR-ABL1+ chronic myeloid leukemia (CML). Following these recommendations, survival of CML patients has become very close to normal.
M. Baccarani   +60 more
semanticscholar   +1 more source

Cholesterol esterification inhibition and imatinib treatment synergistically inhibit growth of BCR-ABL mutation-independent resistant chronic myelogenous leukemia [PDF]

open access: yes, 2017
Since the advent of tyrosine kinase inhibitors (TKIs) such as imatinib, nilotinib, and dasatinib, chronic myelogenous leukemia (CML) prognosis has improved greatly. However, ~30-40% of patients develop resistance to imatinib therapy.
Bandyopadhyay, Shovik   +6 more
core   +3 more sources

Future material demand for automotive lithium-based batteries

open access: yesCommunications Materials, 2020
Lithium-ion-based batteries are a key enabler for the global shift towards electric vehicles. Here, considering developments in battery chemistry and number of electric vehicles, analysis reveals the increasing amounts of lithium, cobalt and nickel that ...
Chengjian Xu   +5 more
doaj   +1 more source

Maritime Anomaly Detection for Vessel Traffic Services: A Survey

open access: yesJournal of Marine Science and Engineering, 2023
A Vessel Traffic Service (VTS) plays a central role in maritime traffic safety. Regulations are given by the International Maritime Organization (IMO) and Guidelines by the International Association of Marine Aids to Navigation and Lighthouse Authorities
Thomas Stach   +3 more
doaj   +1 more source

Evaluation of secreted frizzled-related protein-4 methylation profiles in patients with BCR/ABL positive chronic myeloid leukemia [PDF]

open access: yesWorld Cancer Research Journal, 2021
Objective: Chronic Myeloid Leukemia (CML) is a myeloproliferative disorder characterized by the chromosomal translocation t(9;22) encoding for the Bcr/Abl fusion gene.
M. Pehlivan   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy